Tag: drug discovery market outlook

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Drug Discovery Market Size Shifted, And What Is the Outlook Through 2034?

The expansion of the drug discovery market has been quick-paced in recent years. The market valuation is set to increase from $110.26 billion in 2024 to $124.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.6%. Factors such as advancements in the field of genomics and proteomics, a rising prevalence of chronic diseases, and the advent of biopharmaceuticals contribute to the growth observed in the historical period.

The market size of drug discovery is predicted to witness a swift expansion in the forthcoming years, reaching $217.01 billion by the year 2029 at a Compound Annual Growth Rate (CAGR) of 15.0%. Various factors are contributing to the potential growth over the forecast period such as the adoption of precision medication, concentration on less common diseases and the broadening of individualized treatments. Some of the main trends to look out for during the forecast period include cooperation in drug finding models, special emphasis on rare diseases and orphan drugs, and integrating multi-omics data. Additional factors driving growth include the quick adoption of organoids and 3D cell culture models as well as advancements in virtual screening.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Are the Core Market Drivers Propelling Growth in the Drug Discovery Industry?

The increase in healthcare spending is anticipated to boost the drug discovery market in the future. Globally, a significant portion of countries’ GDP is being allocated to healthcare costs such as hospital care, physicians and clinical services, other professional services, dental care, other health and residential care, personal care, home healthcare, nursing facilities, continuing care retirement communities, prescription drugs among others. The drug discovery segment is a major contributor to these healthcare expenditures as it is vital for disease treatment and extending lifespans. With the emergence of new diseases, the demand for new drugs is escalating. For example, the US-based Centers for Medicare and Medicaid Services reported an increase in national health expenditure by 4.1% to $4.5 trillion in 2022, equating to $13,493 per individual, during the period of 2023–32, it is predicted that average national health expenditure growth (5.6%) will exceed the average GDP growth (4.3%) leading to a rise in healthcare’s GDP share from 17.3 percent in 2022 to 19.7 percent by 2032. Consequently, the hike in healthcare costs is fueling growth in the drug discovery market.

How Is the Drug Discovery Market Segmented?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Which Regions Are Driving the Next Phase of the Drug Discovery Market Growth?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Drug Discovery Industry?

The rise in technological innovation is a significant trend influencing the drug discovery market. Businesses involved in drug discovery are incorporating novel technologies like AI and imaging technology to expedite the drug discovery process. This imaging technology is critical as it enables non-intrusive viewing, characterization, and quantification of biological activities that happen within organisms as a result of drug administration. These methodologies leverage either the strengths of probes or tissues and are vital for disease comprehension and development of new treatments. For example, Google Cloud introduced two AI-driven tools in May 2023, the Target and Lead Identification Suite and the Multiomics Suite. These tools, aimed at biotech and pharmaceutical firms, are built to speed up drug discovery and precision medicine. The Target and Lead Identification Suite aids in determining the roles of amino acids and proteins, while the Multiomics Suite fast-tracks discovery and interpretation of genomic data, thus aiding in designing precise treatments.

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

How Is the Drug Discovery Market Defined and What Are Its Core Parameters?

Drug discovery is the process of identifying biologically active compounds that possess the potential to become therapeutic agents. The drug discovery process involves different phases, from ideation to development to approval. It is used to discover a new clinical drug for treating new, existing, and previously incurable diseases.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7746

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Drug Discovery Market Size Shifted, And What Is the Outlook Through 2034?#_x000D_

The expansion of the drug discovery market has been quick-paced in recent years. The market valuation is set to increase from $110.26 billion in 2024 to $124.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.6%. Factors such as advancements in the field of genomics and proteomics, a rising prevalence of chronic diseases, and the advent of biopharmaceuticals contribute to the growth observed in the historical period._x000D_

_x000D_

The market size of drug discovery is predicted to witness a swift expansion in the forthcoming years, reaching $217.01 billion by the year 2029 at a Compound Annual Growth Rate (CAGR) of 15.0%. Various factors are contributing to the potential growth over the forecast period such as the adoption of precision medication, concentration on less common diseases and the broadening of individualized treatments. Some of the main trends to look out for during the forecast period include cooperation in drug finding models, special emphasis on rare diseases and orphan drugs, and integrating multi-omics data. Additional factors driving growth include the quick adoption of organoids and 3D cell culture models as well as advancements in virtual screening._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Drug Discovery Industry?#_x000D_

The increase in healthcare spending is anticipated to boost the drug discovery market in the future. Globally, a significant portion of countries’ GDP is being allocated to healthcare costs such as hospital care, physicians and clinical services, other professional services, dental care, other health and residential care, personal care, home healthcare, nursing facilities, continuing care retirement communities, prescription drugs among others. The drug discovery segment is a major contributor to these healthcare expenditures as it is vital for disease treatment and extending lifespans. With the emergence of new diseases, the demand for new drugs is escalating. For example, the US-based Centers for Medicare and Medicaid Services reported an increase in national health expenditure by 4.1% to $4.5 trillion in 2022, equating to $13,493 per individual, during the period of 2023–32, it is predicted that average national health expenditure growth (5.6%) will exceed the average GDP growth (4.3%) leading to a rise in healthcare’s GDP share from 17.3 percent in 2022 to 19.7 percent by 2032. Consequently, the hike in healthcare costs is fueling growth in the drug discovery market._x000D_

_x000D_

#How Is the Drug Discovery Market Segmented?#_x000D_

The drug discovery market covered in this report is segmented – _x000D_

_x000D_

1) By Drug Type: Small Molecule, Large Molecule_x000D_

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation_x000D_

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies_x000D_

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas_x000D_

5) By End User: Pharmaceutical Companies, CROs, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs _x000D_

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Drug Discovery Market Growth?#_x000D_

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Drug Discovery Industry?#_x000D_

The rise in technological innovation is a significant trend influencing the drug discovery market. Businesses involved in drug discovery are incorporating novel technologies like AI and imaging technology to expedite the drug discovery process. This imaging technology is critical as it enables non-intrusive viewing, characterization, and quantification of biological activities that happen within organisms as a result of drug administration. These methodologies leverage either the strengths of probes or tissues and are vital for disease comprehension and development of new treatments. For example, Google Cloud introduced two AI-driven tools in May 2023, the Target and Lead Identification Suite and the Multiomics Suite. These tools, aimed at biotech and pharmaceutical firms, are built to speed up drug discovery and precision medicine. The Target and Lead Identification Suite aids in determining the roles of amino acids and proteins, while the Multiomics Suite fast-tracks discovery and interpretation of genomic data, thus aiding in designing precise treatments._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report_x000D_

_x000D_

#How Is the Drug Discovery Market Defined and What Are Its Core Parameters?#_x000D_

Drug discovery is the process of identifying biologically active compounds that possess the potential to become therapeutic agents. The drug discovery process involves different phases, from ideation to development to approval. It is used to discover a new clinical drug for treating new, existing, and previously incurable diseases._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7746_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Drug Discovery Market?

In recent times, there has been a significant increase in the size of the drug discovery market. It is projected to expand from $110.26 billion in 2024 to $125.23 billion in 2025, at a compound annual growth rate (CAGR) of 13.6%. Factors that contributed to this growth in the historic period include improvements in genomics and proteomics, an increasing incidence of chronic diseases, and the advent of biopharmaceuticals.

What Growth Rate Is Forecasted for the Drug Discovery Market by 2029?

The market size for drug discovery is predicted to experience a swift expansion in the coming years, burgeoning to $221.71 billion in 2029 with a compound annual growth rate (CAGR) of 15.3%. The projected growth in this period is credited to the adoption of precision medicine, emphasis on rare diseases, and extended personal therapies. The forecast period is expected to witness major trends such as the implementation of the collaborative drug discovery prototype, concentration on orphan drugs and rare diseases, incorporation of multi-omics data, fast-paced adoption of organoids and 3D cell culture models, and developments in virtual screening.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

Which Key Companies Are Shaping the Future of the Drug Discovery Market?

Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Which Factors Are Driving Demand in the Drug Discovery Industry?

The drug discovery market is predicted to expand as healthcare costs continue to rise. Nations globally are allocating a significant portion of their GDP to healthcare expenditures, which encompasses hospital care, physician and clinical services, other professional services, dental services, various health, residential, and personal care, home health care, nursing care facilities, continuing care retirement communities, prescription drugs, and more. Drug discovery constitutes a substantial fraction of health expenditure since it is essential for the treatment of diseases and extending life expectancy. The necessity for new medications to address emerging diseases is on the rise. For instance, the Centers for Medicare and Medicaid Services, a US federal agency, reported in October 2024 that national health expenditure increased 4.1% reaching $4.5 trillion in 2022, or $13,493 per person. Between 2023 and 2032, the average national health expenditure growth (5.6%) is expected to exceed the average GDP growth (4.3%), raising the health spending share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Hence, the growing healthcare expenditures are fueling the advancement of the drug discovery market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

How Is the Drug Discovery Market Segmented by Several Divisions?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

What are the Emerging Market Trends Driving the Growth of the Drug Discovery Industry?

In the arena of drug discovery, technological advancements are a noteworthy trend. Numerous new technologies like AI, imaging technology, and more are being developed by firms operating in this market to decrease the time needed for discovering drugs. With the aid of imaging technology, non-invasive biological reactions to drugs within organisms can be visualized, quantified, and described. The utilization of these methods, involving probes or tissue, is critical for understanding diseases and developing new treatments. Google Cloud, for instance, in May 2023, introduced two new AI-enhanced tools, the Target and Lead Identification Suite, and the Multiomics Suite to expedite drug discovery and precision medicine. With these tools, biotech and pharmaceutical enterprises can advance their pursuits in drug discovery and precision medicine. The Target and Lead Identification Suite aids in determining the role of proteins and amino acids, while the Multiomics Suite fast tracks the discovery and interpretation of genomic data, therefore assisting in developing precisely targeted treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Regions Are Driving Growth in the Drug Discovery Market?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7746

This Report Delivers Insight On:

1. How big is the drug discovery market, and how is it changing globally?

2. Who are the major companies in the drug discovery market, and how are they performing?

3. What are the key opportunities and risks in the drug discovery market right now?

4. Which products or customer segments are growing the most in the drug discovery market?

5. What factors are helping or slowing down the growth of the drug discovery market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the drug discovery industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Anticipated CAGR of the Drug Discovery Market, and What Factors Will Drive It?#_x000D_

The size of the drug discovery market has seen swift expansion in the past few years. The market, which is projected to be worth $110.26 billion in 2024, is expected to increase to $125.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.6%. Factors contributing to the historic growth include progress in genomics and proteomics, the rising incidence of chronic illnesses, and the advent of biopharmaceuticals._x000D_

_x000D_

The market size for drug discovery is projected to experience a swift expansion in the coming years, reaching $221.71 billion in 2029 with a compound annual growth rate (CAGR) of 15.3%. This growth during the predicted period is due to factors such as the implementation of precision medicine, emphasis on rare diseases, and the growth of personalized therapies. Notable trends during this period include cooperation in drug discovery, increased focus on rare diseases and specially-designated drugs, multi-omics data integration, widespread usage of organoids and 3D cell culture models, as well as developments in virtual screening._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp_x000D_

_x000D_

#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Drug Discovery Market?#_x000D_

The escalation in healthcare costs is anticipated to drive the progression of the drug discovery market. Globally, nations are devoting a substantial portion of their GDP to healthcare, which includes various elements like hospital care, professional services, dental services, personal care, home care, nursing facilities, retirement communities, prescription drugs, and more. Drug discovery constitutes a considerable fraction of these healthcare expenses, due to its necessity in disease treatment and life expectancy extension. With the emergence of new diseases, the demand for novel drugs is on the rise. For example, as reported by the US-based Centers for Medicare and Medicaid Services in October 2024, the national health expenditure witnessed a growth of 4.1% to $4.5 trillion in 2022, or $13,493 per person. Over the forecast period of 2023–32, the average national health expenditure growth (5.6%) is expected to supersede the average GDP growth (4.3%). This is likely to lead to a rise in healthcare expenditure’s GDP share from 17.3 percent in 2022 to 19.7 percent in 2032. Thus, the upward trend in healthcare spending is fuelling the expansion of the drug discovery market._x000D_

_x000D_

#Which Key Market Segments Comprise the Drug Discovery Market and Drive Its Revenue Growth?#_x000D_

The drug discovery market covered in this report is segmented –_x000D_

_x000D_

1) By Drug Type: Small Molecule, Large Molecule_x000D_

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation_x000D_

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies_x000D_

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas_x000D_

5) By End User: Pharmaceutical Companies, CROs, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs_x000D_

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Drug Discovery Market Expansion Across the Globe?#_x000D_

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Key Market Trends in theDrug Discovery Market Over the Coming Years?#_x000D_

The drug discovery market is being significantly influenced by technological innovation. Firms in this sector are employing cutting-edge technologies like AI and imaging technology to speed up the process of drug discovery. Imaging technology in particular allows for biological activity within organisms as they react to medication to be observed, interpreted, and assessed in a non-invasive manner. These tools, harnessing either probes or tissue, are essential for disease understanding and new treatment development. For example, in May 2023, Google Cloud introduced two AI-driven suites, the Target and Lead Identification Suite and the Multiomics Suite, to expedite drug discovery and precision medicine. These tools aim to support biotech and pharmaceutical companies in advancing drug discovery and precision medicine. The function of amino acids and proteins can be identified efficiently with the Target and Lead Identification Suite, while the Multiomics Suite speeds up the discovery and interpretation of genomic data, contributing to the development of precision treatments._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report_x000D_

_x000D_

#How Is the Drug Discovery Market Conceptually Defined?#_x000D_

Drug discovery is the process of identifying biologically active compounds that possess the potential to become therapeutic agents. The drug discovery process involves different phases, from ideation to development to approval. It is used to discover a new clinical drug for treating new, existing, and previously incurable diseases._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7746_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theDrug Discovery Market from 2025 to 2034?

The anticipated increase in healthcare spending is predicted to spur the growth of the drug discovery market. A significant proportion of worldwide GDP is dedicated to healthcare costs, encompassing hospital care, physician and clinic services, assorted professional services, dentistry, other health, residential and personal care, at-home healthcare, nursing facility costs, continuing care retirement communities, prescription medication, and more. The discovery of new drugs is an important component of healthcare spending, as these novel treatments are necessary to combat diseases and extend life expectancy. There is a growing demand for the development of new medications to address emerging diseases. For instance, data from the Centers for Medicare and Medicaid Services, an American federal agency, revealed that in 2024, national health expenditure rose by 4.1% to $4.5 trillion in 2022, equal to $13,493 per individual, between 2023-32. It was also projected that the average national health expenditure growth (5.6%) will surpass the average GDP growth (4.3%), leading to a rise in the proportion of health spending in relation to GDP from 17.3% in 2022 to 19.7% in 2032. Hence, the increase in healthcare costs is fuelling the expansion of the drug discovery market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

#How Does the ProjectedDrug Discovery Market Growth Compare Over the Forecast Period?

In recent times, the market size of drug discovery has witnessed a significant increase. By 2025, it is projected to expand from its 2024 value of $110.26 billion to a substantial $125.23 billion, translating to a compound annual growth rate (CAGR) of 13.6%. Factors like advancements in the fields of genomics and proteomics, a rising incidence of chronic diseases, and the emergence of biopharmaceuticals have contributed to this growth in the historical period.

The market size of drug discovery is predicted to experience swift expansion in the upcoming years, with projections indicating that it will reach $221.71 billion in 2029, growing at a compound annual growth rate (CAGR) of 15.3%. This surge during the forecast period is linked to the uptake of precision medicine, focus on treating rare diseases, and development of personalized therapies. Forecast trends comprise collaborative models for drug discovery, heightened focus on rare diseases and orphan drugs, incorporation of multi-omics data, swift adoption of organoids and 3D cell culture models, and progress in virtual screening.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7746

How Are Market Trends and Innovations Revolutionizing theDrug Discovery Industry in Recent Times?

One of the major tendencies in the drug discovery market is the rise of technological innovation. To shorten the duration of drug discovery, corporations in this sector are introducing unique technologies such as AI, imaging technology and more. The introduction of imaging technology allows for non-invasive viewing, characterization, and quantification of biological processes within organisms reacting to pharmaceuticals. Techniques that leverage the attributes of probes or the tissue itself are essential for understanding diseases and paving the way for new therapies. A case in point, Google Cloud unveiled two AI-empowered tools in May 2023, the Target and Lead Identification Suite and the Multiomics Suite, aimed at speeding up drug discovery and precision medicine. These instruments are intended to support biotech and pharmaceutical firms in progressing drug discovery and precision medicine. The Target and Lead Identification Suite aids in determining the function of amino acids and proteins, while the Multiomics Suite fast-tracks the revelation and interpretation of genomic data, thereby assisting in the formulation of precision treatments.

Which Key Market Players Are Shaping the Future and Growth of theDrug Discovery Market?

Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

What Are the Core Segments of the Drug Discovery Market, and How Do They Contribute to Growth?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

What Regions Are Dominating the Drug Discovery Market Growth?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Drug Discovery Market 2025, By The Business Research Company:

Transport Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/transport-services-global-market-report

Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/services-global-market-report

Insulated Shipping Packaging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulated-shipping-packaging-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the drug discovery market right now?

Over the past few years, there has been a swift expansion in the size of the drug discovery market. The prediction is that it will escalate from $110.26 billion in 2024 to $125.23 billion in 2025, with a compound annual growth rate (CAGR) of 13.6%. The historic growth trend can be traced back to the progress made in genomics and proteomics, increasing occurrence of chronic diseases, and the rise of biopharmaceuticals.

How fast Is the drug discovery market expected to grow, and what’s its future value?

Get your drug discovery market report here!

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

What are the leading drivers of growth in the drug discovery market?

The projected growth in health spending is likely to significantly spur the market for drug discovery. Multiple countries globally are devoting a large portion of their GDP to healthcare costs, encompassing a wide range of services such as hospital care, dental services, physician and clinical services, residential and individual care, home health care, nursing care facilities, and continuing care retirement communities, alongside prescription medications. Drug discovery represents a substantial component of these healthcare expenditures, given its vital role in disease treatment and life extension. There is an escalating demand for novel drugs to address emerging diseases. For instance, data from the Centers for Medicare and Medicaid Services, a federal agency based in the U.S., revealed that national health spending rose 4.1% to $4.5 trillion in 2022 or $13,493 per individual, across 2023–32, anticipating that average national health expenditure growth (5.6%) will surpass average GDP growth (4.3%). This predicts a surge in the health spending portion of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Consequently, the upward trajectory of healthcare spending is acting as a catalyst for the expansion of the drug discovery market.

What are the key segments defining the drug discovery market?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

Who are the key players steering the development of the drug discovery market?

Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

What emerging trends are influencing the growth of the drug discovery market?

Drug discovery market is experiencing a significant shift due to technological innovations. New technologies such as artificial intelligence and imaging technology are being brought forward by companies in the sector in a bid to expedite the drug discovery process. The role of imaging technology is pivotal since it provides a non-invasive view of biological activities within organisms in response to drug interventions, therefore aiding in the quantification, characterization, and visualization of these processes. These techniques, that leverage either tissue-specific or probe-based strengths, are indispensable for disease comprehension and designing fresher treatments. A case in point, Google Cloud in May 2023, unveiled two AI-driven tools, the Target and Lead Identification Suite and the Multiomics Suite, with the intent of expediting drug discovery and precision medicine. These tools are meant to support biotech and pharmaceutical industries in progressing their drug discovery and precision medicine efforts. While the Target and Lead Identification Suite aids in understanding the role and functions of proteins and amino acids, the Multiomics Suite fast-tracks the procurement and understanding of genomic data, thereby assisting in the generation of precision treatment plans.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7746

Which regions are most influential in expanding the drug discovery market?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

AI In Pharma Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

RNA Analysis/ Transcriptomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Research Antibodies and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Growth Rate of the Drop Shipping Market Shape Industry Trends by 2034?

The size of the drug discovery market has seen a swift expansion in the past years. The market is forecasted to increase from $110.26 billion in 2024 to $125.23 billion in 2025, displaying a compound annual growth rate (CAGR) of 13.6%. Factors such as progress in genomics and proteomics, a rising occurrence of chronic conditions, and the arrival of biopharmaceuticals contribute to the growth noted in the historic period.

The size of the drug discovery market is anticipated to experience significant expansion in the forthcoming years, projecting a rise to $221.71 billion by 2029 with a 15.3% compound annual growth rate (CAGR). This growth during the forecast period is mainly driven by the acceptance of precision medicine, emphasizes on rare diseases and the broadening of personalized therapies. Key trends projected for the forecast period encompass partnerships in drug discovery models, concentration on rare diseases and orphan drugs, the incorporation of multi-omics data, the swift adoption of organoids and 3D cell culture models, as well as advancements in virtual screening.

What Major Innovations Are Driving the Accelerated Growth of the Market?

The global drug discovery market is set to expand due to rising healthcare costs. Healthcare expenditures, which represent a significant portion of GDP for many countries, encompass not only hospital and clinical services, but also dental services, personal care, home health care, nursing facilities, retirement communities, prescription medications, and other services. Drug discovery consumes a sizable chunk of these healthcare expenses, as it is crucial for disease treatment and life extension. The emergence of new disease variants necessitates the development of new drugs. For example, the Centers for Medicare and Medicaid Services, a U.S. federal agency, announced in October 2024 that national health expenditures rose 4.1% to $4.5 trillion in 2022, or $13,493 per person, and predicted that the average national health expenditure growth rate (5.6%) would exceed that of the average GDP growth rate (4.3%) from 2023 to 2032, pushing the proportion of GDP devoted to healthcare from 17.3% in 2022 to 19.7% in 2032. Therefore, the surge in healthcare spending fuels the expansion of the drug discovery market.

Get Your Free Sample of the Global Drop Shipping Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

Who Are the Key Market Players Influencing the Growth of the Drop Shipping Industry?

Major companies operating in the drug discovery market include:

• Pfizer Inc._x000D_

• Merck & Co. Inc._x000D_

• Novartis International AG_x000D_

• Thermo Fisher Scientific Inc._x000D_

• WuXi AppTec Group_x000D_

What Key Market Trends Are Shaping the Future of the Drop Shipping Industry?

Innovations in technology serve as a prominent trend within the drug discovery market. Firms within this market are incorporating emerging technological advancements, such as Artificial Intelligence (AI) and imaging technology, to expedite the process of drug discovery. The application of imaging technology allows for the non-invasive visualization, quantification, and characterization of biological activities in organisms responding to drugs. These practices, which utilize either probes or tissue itself, play an essential role in the comprehension of diseases and the development of new treatments. To illustrate, Google Cloud unveiled two AI-enhanced tools, the Target and Lead Identification Suite and the Multiomics Suite, in May 2023 with the intention of hastening the pace of drug discovery and precision medicine. These tools are developed to support biotech and pharmaceutical companies in progressing drug discovery and precision medicine. The Target and Lead Identification Suite aids in identifying the role of amino acids and proteins, while the Multiomics Suite hastens the discovery and interpretation of genomic data, contributing to the development of precision treatments.

Get Instant Access to the Global Drop Shipping Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

What Are the Strategic Segments Comprising the Drop Shipping Market and Their Growth Contributions?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Which Regions Are Emerging as Leaders in the Drop Shipping Market?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Features of the Drop Shipping Market?

Drug discovery is the process of identifying biologically active compounds that possess the potential to become therapeutic agents. The drug discovery process involves different phases, from ideation to development to approval. It is used to discover a new clinical drug for treating new, existing, and previously incurable diseases.

Browse Through More Similar Reports By The Business Research Company:

AI In Pharma Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

RNA Analysis/ Transcriptomics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Research Antibodies and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: